IBS experts Ellie Anderson, Dr. Simone Peters, Beth Rosen, Dr. Prashant Singh, and Dr. Megan Riehl explore the future of digital therapeutics for IBS. Discover Monash University randomized control trial (RCT) breakthroughs on gut-directed hypnotherapy (GDH) and how it can best support you, your clinic, and your IBS patients.
‍
The panelists discussed:

  • The transformative impact of digital therapeutics on IBS pain management.
  • The efficacy of app-delivered GDH for improving symptom severity.
  • Practical steps for clinicians to integrate digital hypnotherapy into care plans to improve patient quality of life.
  • How the research supports a non-pharmacological approach to alleviating IBS-related psychological symptoms.

Complete the form to unlock immediate access to the full panel video.

Refer your patients to Nerva using our HIPAA-compliant form

Contents
Access the RCT panel